Monday’s Plenary Session featured (clockwise, from top left) Serena Nik-Zainal, MD, Ross Levine, MD, Jérôme Galon, PhD, and Garry P. Nolan, PhD.
(Clockwise, from top left) Luis Carvajal-Carmona, PhD, Tiffany Wallace, PhD, Nicole Coggins, PhD, Nora M. Navone, MD, PhD, and Kevin L. Gardner, PhD, took part.
Program Committee Chair Charles Swanton, MBPhD, FAACR, shares some of his selections from the day’s sessions to help plan your Annual Meeting experience.
Investigators in three related sessions shared details about 12 small molecules and biologics in or about to be tested in phase I clinical trials.
Antoni Ribas, MD, PhD, FAACR, discussed how researchers are working to change the treatment paradigm for patients with melanoma and reflected on his term as AACR President.
(Clockwise, from top left) Andrea Schietinger, PhD, Daniela S. Thommen, MD, PhD, E. John Wherry, PhD, and Rachel C. Lynn, PhD, presented data that should help shape understanding of T cell function.
(From left) Jennifer A. Wargo, MD, MMSc, Rob Knight, PhD, and Siew C. Ng, PhD, discussed this emerging topic and will have a live panel session on Wednesday, April 14.
Tuesday’s plenary will feature (clockwise, from top left) Olufunmilayo I. Olopade, MD, FAACR, Tony Hunter, PhD, FAACR, Dennis J. Slamon, MD, PhD, FAACR, and William George Kaelin Jr., MD, FAACR.
Subscribe below to get email updates from AACRMeetingNews.org